Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze BEP stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate BEP investment potential.

What is BEP stock price today?

Get real-time BEP stock price, historical data, and price charts on Financhill. Track BEP performance with our advanced analysis tools.

Is BEP a good investment?

Evaluate BEP investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy BEP stock?

To buy BEP stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of BEP?

View detailed market capitalization data and company valuation metrics for BEP on our comprehensive analysis page.

What is the P/E ratio of BEP?

Use our fundamental analysis tools to view BEP P/E ratio and compare valuation metrics with industry peers.

What are BEP earnings?

View BEP earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Brookfield Renewable Partners LP 10K Form

Buy

BEP
Brookfield Renewable Partners LP

Last Price:

$29.86

Seasonality Move:

1.49%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BEP News And Ratings

See the #1 stock for the next 7 days that we like better than BEP

BEP Financial Statistics

Sales & Book Value

Annual Sales:	$6.4B
Cash Flow:	$-1.4B
Price / Cash Flow:	0
Annual Sales:	$11.03
Price / Book:	2.91

Profitability

EPS (TTM):	-0.27000
Net Income (TTM):	$712M
Gross Margin:	$1.1B
Return on Equity:	2.08%
Return on Assets:	0.73%

Brookfield Renewable Partners LP Earnings Forecast

Key Brookfield Renewable Partners LP Financial Ratios

The Gross Profit Margin over the past 27 years for BEP is 16.84%.
The Selling, General & Administrative Expenses for BEP have been equal to 3.48% of Gross Profit Margin.
The Research & Development expenses have been 0.00% of Revenue.
The Interest Expense is 345.08% of Operating Income.
The Net Earning history of BEP is 11.11% of Total Revenues.
Per Share Earnings over the last 27 years have been positive in 12 years.

Brookfield Renewable Partners LP Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Independent Power & Renewable Electricity Producer
Sector:	Utilities
Current Symbol:	BEP
CUSIP:	G16258
Website:	bep.brookfield.com

Debt

Debt-to-Equity Ratio:	7.58
Current Ratio:	0.54
Quick Ratio:	0.11

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	209.03

BEP Technical Analysis vs Fundamental Analysis

Buy

Brookfield Renewable Partners LP (BEP) is a Buy

Is Brookfield Renewable Partners LP a Buy or a Sell?

Brookfield Renewable Partners LP stock is rated a Buy

The current Brookfield Renewable Partners LP [BEP] share price is $29.83. The Score for BEP is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.